- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06309342
Prevention of Lifestyle-related Disorders Based on Functional Examinations (PREVFUNKTION)
October 4, 2024 updated by: Lena Bornhoft
Prevention of Lifestyle-related Disorders With Early Examinations of Health and Function and Individualised Functional Profiles - a Randomised Controlled Trial
The goal of this randomised controlled trial is to examine the effects of functional examinations and feedback/support on healthy 40-year-olds.
The main questions it aims to answer are: • Does feedback and motivational interviewing after testing physical function motivate inactive middle-aged people to increase their physical activity level?
• Does the intervention lead to health benefits over time - less pain, better function, higher health-related quality of life, fewer risk factors for lifestyle-related illness?
Participants will: • undergo medical and functional health examinations, • their physical activity level will be measured, • receive feedback and advice based on both parts of the examinations, • receive a functional profile, • be supported in goalsetting for lifestyle changes.
Researchers will compare with a control group who, after the examinations, receive feedback only from the medical examination to see if participants become more physically active, achieve better function, become more motivated to make lifestyle changes, reduce risk factors for lifestyle-related illness, achieve health benefits and better health-related quality of life.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Relatively healthy 40-year-olds will be examined at baseline and 1 year with both standard medical and newly developed functional examinations and physical activity level will be measured with accelerometers.
The intervention group will receive feedback on all their results.
A functional profile will be compiled and explained to each participant and they will receive support in setting relevant goals for lifestyle changes and making realistic plans to achieve them.
The control group will also be examined as above but will receive feedback and advice based only on the standard medical examination.
Study Type
Interventional
Enrollment (Estimated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lena Bornhöft, PhD
- Phone Number: +46 761408320
- Email: lena.bornhoft@vgregion.se
Study Locations
-
-
Region Västra Götaland
-
Mölnlycke, Region Västra Götaland, Sweden, 43544
- Recruiting
- Familjeläkarna i Mölnlycke
-
Contact:
- Kinna Helgesson
- Phone Number: 46 31681400
- Email: kinna.h@flmolnlycke.se
-
Contact:
- Camilla Olofsson
- Phone Number: 46 31681400
- Email: camillao@flmolnlycke.se
-
Principal Investigator:
- Lena Bornhöft, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 40 years of age
- Relatively normal general mobility - can walk without support and have no self-reported difficulties with using all four extremities - in order to be able to perform standardised functional performance tests.
- Self-assessed as physically inactive (level 1 or 2 on the Saltin Grimby Physical Activity Level Scale) as inactive people stand to gain most from this intervention.
Exclusion Criteria:
- Verbally self-reported physical activity at level three or four on Saltin Grimby Physical Activity Level Scale.
- Severe mental illness or intellectual impairment, as participants will be expected to fill out questionnaires and should have the ability to follow healthcare advice independently should they choose to do so.
- Pregnancy and/or on-going treatment requiring hospital-based services, to increase probability of baseline values which reflect usual capacity.
- No language restrictions are planned but participants needing interpreter help should arrange this themselves.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PREVFUNKTION
Medical examination.
Functional examination.
Measurement of physical activity.
Questionnaires on health, function and lifestyle.
Feedback and advice based on medical examination.
Feedback and advice based on functional examination.
Functional profile.
Support in setting goals for lifestyle changes.
|
Functional profile and advice concerning cardiovascular fitness level, strength, mobility, balance and posture.
Motivational interview and support in goalsetting to make lifestyle changes.
Physical activity measured with accelerometers.
Functional examination.
Medical examination and advice concerning weight measures, blood pressure and standard blood tests.
|
|
Active Comparator: Control
Medical examination.
Functional examination.
Measurement of physical activity.
Questionnaires on health, function and lifestyle.
Feedback and advice based on medical examination.
|
Physical activity measured with accelerometers.
Functional examination.
Medical examination and advice concerning weight measures, blood pressure and standard blood tests.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in objectively measured physical activity
Time Frame: Change between baseline and 1-year follow-up
|
Mean daily minutes in moderate-to-very vigorous physical activity measured with accelerometers for 1 week
|
Change between baseline and 1-year follow-up
|
|
Change in objectively measured sedentary behaviour
Time Frame: Change between baseline and 1-year follow-up
|
Mean daily minutes of sedentary behaviour measured with accelerometers for 1 week
|
Change between baseline and 1-year follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in cardiovascular fitness
Time Frame: Change between baseline and 1-year follow-up
|
Fitness level measured in ml/kg/min using the Ekblom Bak submaximal ergometer test
|
Change between baseline and 1-year follow-up
|
|
Change in motivation level
Time Frame: Change between baseline and 1-year follow-up
|
Motivation to make lifestyle changes to improve health on an 11-point numerical rating scale.
|
Change between baseline and 1-year follow-up
|
|
Proportion achieved goals
Time Frame: Measured only at 1-year follow-up
|
Proportion of goals achieved of the goals set by the intervention group at baseline
|
Measured only at 1-year follow-up
|
|
Change in fitness level
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for fitness where points are given for grade of deviation from norm.
Minimum -2, maximum +2.
Higher scores indicate better fitness level.
|
Change between baseline and 1-year follow-up
|
|
Change in strength upper extremity
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for strength upper extremity where points are given for grade of deviation from norm.
Minimum -2, maximum +2.
Higher scores indicate better strength.
|
Change between baseline and 1-year follow-up
|
|
Change in strength lower extremity
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for strength lower extremity where points are given for grade of deviation from norm.
Minimum -2, maximum +2.
Higher scores indicate better strength.
|
Change between baseline and 1-year follow-up
|
|
Change in strength trunk muscles
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for strength trunk where points are given for grade of deviation from norm.
Minimum -2, maximum +2.
Higher scores indicate better strength.
|
Change between baseline and 1-year follow-up
|
|
Change in balance
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for balance where points are given for grade of deviation from norm.
Minimum -2, maximum +2.
Higher scores indicate better balance.
|
Change between baseline and 1-year follow-up
|
|
Change in mobility
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for mobility where points are given for grade of deviation from norm.
Minimum -2, maximum 0. Lower score indicates mobility dysfunction, 0 indicates normal mobility.
|
Change between baseline and 1-year follow-up
|
|
Change in posture
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for posture where points are given for grade of deviation from norm.
Minimum -1, maximum 0. Lower score indicates postural deviations, 0 indicates normal postural measurements.
|
Change between baseline and 1-year follow-up
|
|
Change in weight measures
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for weight where points are given for grade of deviation from recommended values.
Minimum -2, maximum 0. Lower score indicates overweight (or underweight), 0 indicates normal weight.
|
Change between baseline and 1-year follow-up
|
|
Change in pain
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for pain where points are given for number of pain locations, score on the Örebro Musculoskeletal Pain Screening Questionnaire and on the pain question on Euroqol-5 dimensions-3 levels.
Minimum -2, maximum 0. Lower score indicates more pain, 0 indicates no pain.
|
Change between baseline and 1-year follow-up
|
|
Change in physical activity
Time Frame: Change between baseline and 1-year follow-up
|
Point level on the study-specific functional profile arm for physical activity where points are given for grade of deviation from recommended values when objectively measured with accelerometers.
Minimum -2, maximum +2.
Increased point value indicates higher physical activity level.
|
Change between baseline and 1-year follow-up
|
|
Change in handgrip strength
Time Frame: Change between baseline and 1-year follow-up
|
Measured with Jamar handdynamometer (kg)
|
Change between baseline and 1-year follow-up
|
|
Change in biceps strength
Time Frame: Change between baseline and 1-year follow-up
|
Measured with 30-second biceps test (number repetitions)
|
Change between baseline and 1-year follow-up
|
|
Change in leg strength
Time Frame: Change between baseline and 1-year follow-up
|
Measured with 30-second chair-stand test (number repetitions)
|
Change between baseline and 1-year follow-up
|
|
Change in calf strength
Time Frame: Change between baseline and 1-year follow-up
|
Measured with single-foot heel rises (number repetitions)
|
Change between baseline and 1-year follow-up
|
|
Change in ventral trunk strength
Time Frame: Change between baseline and 1-year follow-up
|
Measured with plank test (seconds)
|
Change between baseline and 1-year follow-up
|
|
Change in dorsal trunk strength
Time Frame: Change between baseline and 1-year follow-up
|
Measured with back endurance test (seconds)
|
Change between baseline and 1-year follow-up
|
|
Change in lower trunk strength
Time Frame: Change between baseline and 1-year follow-up
|
Measured with supine bridge test (seconds)
|
Change between baseline and 1-year follow-up
|
|
Change in static balance - 1
Time Frame: Change between baseline and 1-year follow-up
|
Measured with stand-on-one-leg-eyes-open test (seconds)
|
Change between baseline and 1-year follow-up
|
|
Change in static balance - 2
Time Frame: Change between baseline and 1-year follow-up
|
Measured with stand-on-one-leg-eyes-closed test (seconds)
|
Change between baseline and 1-year follow-up
|
|
Change in static balance - 3
Time Frame: Change between baseline and 1-year follow-up
|
Measured with sharpened Romberg test (seconds)
|
Change between baseline and 1-year follow-up
|
|
Change in dynamic balance
Time Frame: Change between baseline and 1-year follow-up
|
Measured with functional reach test (centimeters)
|
Change between baseline and 1-year follow-up
|
|
Change in mobility - 1
Time Frame: Change between baseline and 1-year follow-up
|
Measured with sit-rise test (points)
|
Change between baseline and 1-year follow-up
|
|
Change in mobility - 2
Time Frame: Change between baseline and 1-year follow-up
|
Measured with finger-floor test (centimeters)
|
Change between baseline and 1-year follow-up
|
|
Change in mobility - 3
Time Frame: Change between baseline and 1-year follow-up
|
Measured with lateral flexion test (centimeters)
|
Change between baseline and 1-year follow-up
|
|
Change in hypermobility score
Time Frame: Change between baseline and 1-year follow-up
|
Measured with Beighton hypermobility score with point values between 0 and 9 where score over 4 indicate general hypermobility.
|
Change between baseline and 1-year follow-up
|
|
Change in neck mobility
Time Frame: Change between baseline and 1-year follow-up
|
Measured with occiput-to-wall test (points)
|
Change between baseline and 1-year follow-up
|
|
Change in foot pronation
Time Frame: Change between baseline and 1-year follow-up
|
Measured with navicular drop test (millimeters)
|
Change between baseline and 1-year follow-up
|
|
Change in habitual stance
Time Frame: Change between baseline and 1-year follow-up
|
Measured with patella mobility test (points)
|
Change between baseline and 1-year follow-up
|
|
Change in health-related quality of life assessed with EQ5D index
Time Frame: Change between baseline and 1-year follow-up
|
Measured with index values for Euroqol-5 dimensions-3 levels.
Minimum -0.59, maximum +1.
Higher scores indicate better health-related quality of life.
|
Change between baseline and 1-year follow-up
|
|
Change in health-related quality of life assessed with EQ5D VAS
Time Frame: Change between baseline and 1-year follow-up
|
Measured with the 100-point barometer for Euroqol-5 dimensions-3 levels.
Minimum 0, maximum 100.
Higher scores indicate better health-related quality of life.
|
Change between baseline and 1-year follow-up
|
|
Change in self-reported physical activity assessed with Swedish questionnaire
Time Frame: Change between baseline and 1-year follow-up
|
Measured with Swedish National Board of Health and Welfare questionnaire with 2 questions on physical activity and exercise measured in minutes.
Minimum 0, maximum measured value 540.
Increasing values indicate higher levels of physical activity.
|
Change between baseline and 1-year follow-up
|
|
Change in self-reported physical activity assessed with Saltin Grimby Physical Activity Level Scale (SGPALS)
Time Frame: Change between baseline and 1-year follow-up
|
Measured with SGPALS with point values between 1 and 4 where increasing values indicate higher level of physical activity.
|
Change between baseline and 1-year follow-up
|
|
Change in self-reported sedentary time
Time Frame: Change between baseline and 1-year follow-up
|
Measured in hours per day with SED-GIH questionnaire with values between 0 and 24 where increasing sedentary time is considered to have a negative impact on health.
|
Change between baseline and 1-year follow-up
|
|
Change in risk for chronic pain and sickness absence assessed with Örebro Musculoskeletal Pain Screening Questionnaire
Time Frame: Change between baseline and 1-year follow-up
|
Measured with Örebro Musculoskeletal Pain Screening Questionnaire with scores between 1 and 100 where increasing values indicate higher risk for chronic pain and sickness absence.
|
Change between baseline and 1-year follow-up
|
|
Change in number of pain locations
Time Frame: Change between baseline and 1-year follow-up
|
Measured with a pain diagram
|
Change between baseline and 1-year follow-up
|
|
Change in proportion smokers
Time Frame: Change between baseline and 1-year follow-up
|
Proportion smokers in each group
|
Change between baseline and 1-year follow-up
|
|
Change in proportion acceptable level blood glucose
Time Frame: Change between baseline and 1-year follow-up
|
Proportion with blood glucose levels within recommended limits (4.0-6.0 mmol/L)
|
Change between baseline and 1-year follow-up
|
|
Change in proportion acceptable level serum cholesterol
Time Frame: Change between baseline and 1-year follow-up
|
Proportion with cholesterol levels within recommended limits (3.3-6.9 mmol/L)
|
Change between baseline and 1-year follow-up
|
|
Change in proportion acceptable level triglycerides
Time Frame: Change between baseline and 1-year follow-up
|
Proportion with triglyceride levels within recommended limits (0,45-2.6)
|
Change between baseline and 1-year follow-up
|
|
Change in proportion acceptable blood pressure
Time Frame: Change between baseline and 1-year follow-up
|
Proportion of participants with blood pressure within recommended limits
|
Change between baseline and 1-year follow-up
|
|
Change in proportion normal body mass index (BMI)
Time Frame: Change between baseline and 1-year follow-up
|
Proportion of participants with BMI within recommended limits
|
Change between baseline and 1-year follow-up
|
|
Change in proportion acceptable waist circumference
Time Frame: Change between baseline and 1-year follow-up
|
Proportion of participants with waist circumference below recommended level
|
Change between baseline and 1-year follow-up
|
|
Change in stress symptoms assessed with Stress and Crisis Inventory-93
Time Frame: Change between baseline and 1-year follow-up
|
Measured with Stress and Crisis Inventory-93 questionnaire.
Minimum 0, maximum 140, with higher values indicating higher stress levels.
|
Change between baseline and 1-year follow-up
|
|
Change in depression and anxiety symptoms assessed with Hospital Anxiety and Depression Scale
Time Frame: Change between baseline and 1-year follow-up
|
Measured with Hospital Anxiety and Depression Scale.
Minimum 0, maximum 42 with 21 as maximum for anxiety and 21 maximum for depression.
Increasing values indicate more severe symptoms.
|
Change between baseline and 1-year follow-up
|
|
Correlation between self-assessed and objectively measured fitness
Time Frame: Change between baseline and 1-year follow-up
|
Correlation between fitness self-assessed on a 5-point Likert scale and point value on the fitness arm on the study-specific functional profile.
Minimum -1, maximum +1.
Higher values indicate better correlation between the 2 measures.
|
Change between baseline and 1-year follow-up
|
|
Correlation between self-assessed and objectively measured fitness - 2
Time Frame: Change between baseline and 1-year follow-up
|
Correlation between fitness self-assessed on a 5-point Likert scale and fitness grade on the Ekblom Bak fitness test (5 point Likert scale).
Minimum -1, maximum +1.
Higher values indicate better correlation between the 2 measures.
|
Change between baseline and 1-year follow-up
|
|
Correlation between self-assessed and objectively measured strength upper extremity
Time Frame: Change between baseline and 1-year follow-up
|
Correlation between upper extremity strength self-assessed on a 5-point Likert scale and point value for the strength upper extremity arm on the study-specific functional profile.
Minimum -1, maximum +1.
Higher values indicate better correlation between the 2 measures.
|
Change between baseline and 1-year follow-up
|
|
Correlation between self-assessed and objectively measured strength lower extremity
Time Frame: Change between baseline and 1-year follow-up
|
Correlation between lower extremity strength self-assessed on a 5-point Likert scale and point value for the strength lower extremity arm on the study-specific functional profile.
Minimum -1, maximum +1.
Higher values indicate better correlation between the 2 measures.
|
Change between baseline and 1-year follow-up
|
|
Correlation between self-assessed and objectively measured balance
Time Frame: Change between baseline and 1-year follow-up
|
Correlation between balance self-assessed on a 5-point Likert scale and point value on the balance arm on the study-specific functional profile.
Minimum -1, maximum +1.
Higher values indicate better correlation between the 2 measures.
|
Change between baseline and 1-year follow-up
|
|
Correlation between self-assessed and objectively measured physical activity
Time Frame: Change between baseline and 1-year follow-up
|
Correlation between self-assessed walking ability on a 5-point Likert scale and point value on the physical activity arm on the study-specific functional profile.
Minimum -1, maximum +1.
Higher values indicate better correlation between the 2 measures.
|
Change between baseline and 1-year follow-up
|
|
Correlation between self-assessed and objectively measured physical activity - 2
Time Frame: Change between baseline and 1-year follow-up
|
Correlation between self-assessed walking ability on a 5-point Likert scale and number of daily minutes in moderate-to-very vigorous physical activity measured with accelerometers.
Minimum -1, maximum +1.
Higher values indicate better correlation between the 2 measures.
|
Change between baseline and 1-year follow-up
|
|
Change in relative physical activity
Time Frame: Change between baseline and 1-year follow-up
|
Mean daily minutes of moderate-to-very vigorous physical activity measured with accelerometers for 1 week where moderate is individually calculated in relation to fitness level (46% of VO2max).
|
Change between baseline and 1-year follow-up
|
|
Change in sufficient physical activity
Time Frame: Change between baseline and 1-year follow-up
|
Number of mean daily minutes of physical activity measured with accelerometers for 1 week above a known health-promoting level based on a fitness level of 31.5 ml/kg for women and 35 ml/kg for men.
|
Change between baseline and 1-year follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lena Bornhöft, PhD, Region Västra Götaland, University of Gothenburg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 19, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
February 29, 2024
First Submitted That Met QC Criteria
March 6, 2024
First Posted (Actual)
March 13, 2024
Study Record Updates
Last Update Posted (Actual)
October 8, 2024
Last Update Submitted That Met QC Criteria
October 4, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- VGRFOU-278257
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lifestyle-related Condition
-
Amsterdam UMC, location VUmcAchmeaCompletedLifestyle-related ConditionNetherlands
-
Boston Heart DiagnosticsDavid M. Katz, M.D.UnknownLifestyle-related Condition | Nutrient; Excess
-
University of California, MercedNational Cancer Institute (NCI)CompletedNutrition | Lifestyle-related Condition | Sugar Sweetened Beverage Consumption | Lifestyle Risk ReductionUnited States
-
Fundación Pública Andaluza para la gestión de la...Andaluz Health Service; European CommissionCompletedSmoking Cessation | Health Behavior | Lifestyle-related Condition
-
Marmara UniversityCompletedLifestyle-related ConditionTurkey
-
Finis Terrae UniversityRecruitingMetabolic Diseases | Healthy Aging | Lifestyle-related ConditionChile
-
Paola VitaglioneRecruitingLifestyle-related ConditionItaly
-
Umeå UniversityActive, not recruitingHypertension,Essential | Lifestyle-related ConditionSweden
-
Universitat Jaume IUnknownCORE Condition | Healthy Lifestyle Psychoeducational Program | Waiting List ControlArgentina, Mexico, Spain
-
The New Model of Care, Hail Health ClusterHealth Holding Company, Hail Health Cluster, Saudi ArabiaRecruitingLifestyle-related ConditionSaudi Arabia